Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RT002
RT002
Settle down, Allergan investors. Botox's market share is safe, analysts say
Fierce Pharma
Wed, 12/6/17 - 11:11 am
Allergan
Botox
wrinkle treatment
ReVance
RT002
Watch out Allergan: Revance’s wrinkle-reducer beats Botox in PhIII trials
Endpoints
Tue, 12/5/17 - 09:31 am
Allergan
ReVance
Botox
clinical trials
RT002
wrinkle treatments
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002